The independent source for health policy research, polling, and news.
1-20 of 560 results
State leaders who scrambled to win and begin spending their first-year shares of Republicans’ five-year, $50 billion fund are in the dark about how much they’ll receive in the Rural Health Transformation Program’s second year after a federal office notified states that more time is needed to make allocations.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Experimental peptides are all the rage on longevity and “optimization” podcasts, but a lot of the chatter is misleading.
The anti-fraud efforts highlight a broader political fight ahead of the midterms. Republicans say they’re protecting taxpayer dollars by going after bad actors. Democrats contend the administration is — with insufficient evidence — targeting blue states to cut programs the GOP has long sought to shrink.
The Trump administration has provided few details about its process for canceling hundreds of thousands of Affordable Care Act marketplace enrollments — even as the next stage of the anti-fraud effort is underway.
People who have taken experimental peptides, such as BPC-157, complain of migraines, eye pain, fatigue, and more. Learning whether these popular but unproven drugs are to blame may become harder if Robert F. Kennedy Jr. fulfills a promise to make them more accessible.
A Slack workspace managed by the Centers for Medicare & Medicaid Services has served as an extraordinary war room for AI industry insiders and Trump administration officials to launch a rapid campaign aimed at persuading Americans to manage their healthcare and medical records on apps.
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Recent outbreaks of foodborne illness and high-profile recalls have made this issue a concern of voters.
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
To get drugs and devices out faster, the FDA lets companies conduct studies of safety or efficacy after the products are approved. In many cases, such “postmarket” studies are behind schedule or overdue, records show.
An experiment to provide meals to some Medicaid recipients shows food can be cost-effective medicine. But even as federal officials tout the power of nutrition, Medicaid budget cuts could lead states to think twice about covering healthy food for sick residents. One has already reconsidered.
The agreements, covering issues like drug pricing, reducing the use of synthetic food dyes, and cutting back on insurance prior authorization rules, were announced with fanfare and touted as victories. But it’s not clear whether they’ll result in lasting change.
States must submit Rural Health Transformation Program progress reports to the federal government, but they aren’t required to proactively post those reports, or related information, publicly.
The Department of Health and Human Services has launched an effort to streamline clinical research, and legislation is pending in Congress. But patients and providers face participation challenges.
The Trump administration is working to implement the president’s new order on childhood vaccines, which he publicly faulted for a rise in autism — even as health secretary Robert F. Kennedy Jr.’s closed-door research has yet to produce evidence linking them.
Rising premiums forced many people in Affordable Care Act plans to give up their coverage. But the Trump administration claims a huge drop in enrollment is almost entirely due to its fraud crackdown.
The Department of Justice in June issued a legal opinion saying states aren’t required to provide services that help people with disabilities remain in their homes. The new position has added momentum to states’ existing legal challenges to the requirement and triggered worries among people who rely on these services.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
They’re known for touting pandemic precautions, Affordable Care Act plans, and testing for lead in schools. This year, some former public health officials are touting themselves — for governor or senator.
© 2026 KFF